Tucker Joseph D, Meyers Kathrine, Best John, Kaplan Karyn, Pendse Razia, Fenton Kevin A, Andrieux-Meyer Isabelle, Figueroa Carmen, Goicochea Pedro, Gore Charles, Ishizaki Azumi, Khwairakpam Giten, Miller Veronica, Mozalevskis Antons, Ninburg Michael, Ocama Ponsiano, Peeling Rosanna, Walsh Nick, Colombo Massimo G, Easterbrook Philippa
University of North Carolina Chapel Hill Project-China, Number 2 Lujing Road, Guangzhou, 510095, China.
Institute of Global Health and Infectious Diseases, University of North Carolina Chapel Hill, 130 Mason Farm Rd, CB# 7030, Chapel Hill, NC, 27599-7030, USA.
BMC Infect Dis. 2017 Nov 1;17(Suppl 1):701. doi: 10.1186/s12879-017-2771-4.
Innovation contests are a novel approach to elicit good ideas and innovative practices in various areas of public health. There remains limited published literature on approaches to deliver hepatitis testing. The purpose of this innovation contest was to identify examples of different hepatitis B and C approaches to support countries in their scale-up of hepatitis testing and to supplement development of formal recommendations on service delivery in the 2017 World Health Organization hepatitis B and C testing guidelines.
This contest involved four steps: 1) establishment of a multisectoral steering committee to coordinate a call for contest entries; 2) dissemination of the call for entries through diverse media (Facebook, Twitter, YouTube, email listservs, academic journals); 3) independent ranking of submissions by a panel of judges according to pre-specified criteria (clarity of testing model, innovation, effectiveness, next steps) using a 1-10 scale; 4) recognition of highly ranked entries through presentation at international conferences, commendation certificate, and inclusion as a case study in the WHO 2017 testing guidelines.
The innovation contest received 64 entries from 27 countries and took a total of 4 months to complete. Sixteen entries were directly included in the WHO testing guidelines. The entries covered testing in different populations, including primary care patients (n = 5), people who inject drugs (PWID) (n = 4), pregnant women (n = 4), general populations (n = 4), high-risk groups (n = 3), relatives of people living with hepatitis B and C (n = 2), migrants (n = 2), incarcerated individuals (n = 2), workers (n = 2), and emergency department patients (n = 2). A variety of different testing delivery approaches were employed, including integrated HIV-hepatitis testing (n = 12); integrated testing with harm reduction and addiction services (n = 9); use of electronic medical records to support targeted testing (n = 8); decentralization (n = 8); and task shifting (n = 7).
The global innovation contest identified a range of local hepatitis testing approaches that can be used to inform the development of testing strategies in different settings and populations. Further implementation and evaluation of different testing approaches is needed.
创新竞赛是在公共卫生各个领域激发好想法和创新实践的一种新方法。关于开展肝炎检测的方法,已发表的文献仍然有限。本次创新竞赛的目的是确定不同的乙型和丙型肝炎检测方法实例,以支持各国扩大肝炎检测规模,并补充2017年世界卫生组织乙型和丙型肝炎检测指南中关于服务提供的正式建议的制定。
本次竞赛包括四个步骤:1)成立一个多部门指导委员会,以协调竞赛参赛作品的征集;2)通过多种媒体(脸书、推特、优兔、电子邮件列表、学术期刊)传播参赛作品征集信息;3)由一个评审小组根据预先指定的标准(检测模式的清晰度、创新性、有效性、后续步骤),采用1至10分制对提交的作品进行独立排名;4)通过在国际会议上展示、颁发嘉奖证书以及作为案例研究纳入世卫组织2017年检测指南,对排名靠前的参赛作品予以认可。
本次创新竞赛共收到来自27个国家的64份参赛作品,整个竞赛共耗时4个月完成。16份参赛作品被直接纳入世卫组织检测指南。参赛作品涵盖了不同人群的检测,包括初级保健患者(5份)、注射吸毒者(4份)、孕妇(4份)、普通人群(4份)、高危人群(3份)、乙型和丙型肝炎患者的亲属(2份)、移民(2份)、被监禁者(2份)、工人(2份)以及急诊科患者(2份)。采用了多种不同的检测提供方法,包括艾滋病毒 - 肝炎联合检测(12份);与减少伤害和成瘾服务联合检测(9份);利用电子病历支持靶向检测(8份);去中心化(8份);以及任务转移(7份)。
全球创新竞赛确定了一系列当地肝炎检测方法,可用于为不同环境和人群的检测策略制定提供参考。需要对不同的检测方法进行进一步的实施和评估。